{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:13:48Z","timestamp":1792653228514,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2873,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/labinvest.2014.145","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T08:35:10Z","timestamp":1418632510000},"page":"342-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis"],"prefix":"10.1016","volume":"95","author":[{"given":"Minrui","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingluo","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2014.145_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jcp.2004.019224","article-title":"Alterations of mononuclear inflammatory cells, CD4\/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis","volume":"58","author":"Hussein","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1038\/labinvest.2014.145_bib2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ncprheum0618","article-title":"Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma","volume":"3","author":"Deleuran","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1038\/labinvest.2014.145_bib3","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2014.145_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","article-title":"Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?","volume":"50","author":"Murata","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1038\/labinvest.2014.145_bib5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","article-title":"Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions","volume":"71","author":"Mathian","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/labinvest.2014.145_bib6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2014.145_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature12614","article-title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma","volume":"503","author":"Gerber","year":"2013","journal-title":"Nature"},{"key":"10.1038\/labinvest.2014.145_bib8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/jid.2013.130","article-title":"Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis","volume":"133","author":"Hinchcliff","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2014.145_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2014.145_bib10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.24395","article-title":"The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis","volume":"60","author":"Akhmetshina","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2014.145_bib11","first-page":"467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scalE","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J ClinPathol"},{"key":"10.1038\/labinvest.2014.145_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/labinvest.2014.145_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.2209","article-title":"CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation","volume":"16","author":"Marcos","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2014.145_bib14","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2013-02-486217","article-title":"Mast cell and macrophage chemokines CXCL1\/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation","volume":"121","author":"De Filippo","year":"2013","journal-title":"Blood"},{"key":"10.1038\/labinvest.2014.145_bib15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/jir.2006.0064","article-title":"Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity","volume":"27","author":"Kusumoto","year":"2007","journal-title":"J Interferon Cytok Res"},{"key":"10.1038\/labinvest.2014.145_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/eji.200324429","article-title":"Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells","volume":"34","author":"Mariani","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1038\/labinvest.2014.145_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J Pathol"},{"key":"10.1038\/labinvest.2014.145_bib18","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/labinvest.2014.145_bib19","doi-asserted-by":"crossref","first-page":"L736","DOI":"10.1152\/ajplung.00210.2013","article-title":"Bleomycin delivery by osmotic mini-pump: similarity to human scleroderma interstitial lung disease","volume":"306","author":"Lee","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1038\/labinvest.2014.145_bib20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0022-3565(25)39287-6","article-title":"High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis","volume":"243","author":"Harrison","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/labinvest.2014.145_bib21","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1073\/pnas.80.10.3064","article-title":"Metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity","volume":"80","author":"Lazo","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2014.145_bib22","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2014.145_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1165\/rcmb.2002-0009OC","article-title":"Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis","volume":"27","author":"Belperio","year":"2002","journal-title":"Am J Resp Cell Mol Biol"},{"key":"10.1038\/labinvest.2014.145_bib24","first-page":"1202","article-title":"Macrophage infiltration in the skin of patients with systemic-sclerosis","volume":"19","author":"Ishikawa","year":"1992","journal-title":"J Rheum"},{"key":"10.1038\/labinvest.2014.145_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/labinvest.2014.145_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J Leuk Biol"},{"key":"10.1038\/labinvest.2014.145_bib27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.coi.2007.05.007","article-title":"Alternatively activated macrophages in protozoan infections","volume":"19","author":"Raesl","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1038\/labinvest.2014.145_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/labinvest.2014.145_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1600-0625.2008.00828.x","article-title":"Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma","volume":"18","author":"Higashi-Kuwata","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1038\/labinvest.2014.145_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2010.133587","article-title":"Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?","volume":"70","author":"Barnes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/labinvest.2014.145_bib31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.46.4.302","article-title":"Polymorphonuclear neutrophil function in systemic sclerosis","volume":"46","author":"Czirjak","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/labinvest.2014.145_bib32","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/rheumatology\/ker520","article-title":"Neutrophil-derived reactive oxygen species in SSc","volume":"51","author":"Barnes","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1038\/labinvest.2014.145_bib33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1089\/ars.2013.5298","article-title":"Oxidative stress elicits platelet\/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis","volume":"20","author":"Maugeri","year":"2014","journal-title":"Antioxid Redox Signal"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2014145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2014145","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372202298X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372202298X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2014145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:47:44Z","timestamp":1758397664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002368372202298X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S002368372202298X"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2014.145","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2014.145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}